Stephens Consulting’s Pfizer PFE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $53.6K | Sell |
2,210
-244
| -10% | -$5.92K | 0.01% | 185 |
|
2025
Q1 | $62.2K | Sell |
2,454
-3,372
| -58% | -$85.4K | 0.02% | 168 |
|
2024
Q4 | $155K | Buy |
5,826
+2,318
| +66% | +$61.5K | 0.04% | 110 |
|
2024
Q3 | $102K | Sell |
3,508
-405
| -10% | -$11.7K | 0.03% | 133 |
|
2024
Q2 | $109K | Buy |
3,913
+259
| +7% | +$7.25K | 0.03% | 126 |
|
2024
Q1 | $101K | Sell |
3,654
-1,191
| -25% | -$33.1K | 0.03% | 124 |
|
2023
Q4 | $139K | Buy |
4,845
+1,000
| +26% | +$28.8K | 0.05% | 99 |
|
2023
Q3 | $128K | Buy |
3,845
+525
| +16% | +$17.4K | 0.05% | 101 |
|
2023
Q2 | $122K | Sell |
3,320
-75
| -2% | -$2.75K | 0.05% | 96 |
|
2023
Q1 | $139K | Sell |
3,395
-4
| -0.1% | -$163 | 0.08% | 91 |
|
2022
Q4 | $174K | Hold |
3,399
| – | – | 0.12% | 80 |
|
2022
Q3 | $149K | Buy |
3,399
+248
| +8% | +$10.9K | 0.13% | 80 |
|
2022
Q2 | $165K | Sell |
3,151
-1,070
| -25% | -$56.1K | 0.13% | 76 |
|
2022
Q1 | $219K | Sell |
4,221
-880
| -17% | -$45.6K | 0.18% | 72 |
|
2021
Q4 | $301K | Buy |
+5,101
| New | +$301K | 0.25% | 65 |
|